Anti-SNPH monoclonal antibody

Pre-made anti-SNPH monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SNPH/SNPH products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1781-Ab-1/ GM-Tg-hg-IP1781-Ab-2Anti-Human SNPH monoclonal antibodyHuman
GM-Tg-rg-IP1781-Ab-1/ GM-Tg-rg-IP1781-Ab-2Anti-Rat SNPH monoclonal antibodyRat
GM-Tg-mg-IP1781-Ab-1/ GM-Tg-mg-IP1781-Ab-2Anti-Mouse SNPH monoclonal antibodyMouse
GM-Tg-cynog-IP1781-Ab-1/ GM-Tg-cynog-IP1781-Ab-2Anti-Cynomolgus/ Rhesus macaque SNPH monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1781-Ab-1/ GM-Tg-felg-IP1781-Ab-2Anti-Feline SNPH monoclonal antibodyFeline
GM-Tg-cang-IP1781-Ab-1/ GM-Tg-cang-IP1781-Ab-2Anti-Canine SNPH monoclonal antibodyCanine
GM-Tg-bovg-IP1781-Ab-1/ GM-Tg-bovg-IP1781-Ab-2Anti-Bovine SNPH monoclonal antibodyBovine
GM-Tg-equg-IP1781-Ab-1/ GM-Tg-equg-IP1781-Ab-2Anti-Equine SNPH monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1781-Ab-1/ GM-Tg-hg-IP1781-Ab-2; GM-Tg-rg-IP1781-Ab-1/ GM-Tg-rg-IP1781-Ab-2;
GM-Tg-mg-IP1781-Ab-1/ GM-Tg-mg-IP1781-Ab-2; GM-Tg-cynog-IP1781-Ab-1/ GM-Tg-cynog-IP1781-Ab-2;
GM-Tg-felg-IP1781-Ab-1/ GM-Tg-felg-IP1781-Ab-2; GM-Tg-cang-IP1781-Ab-1/ GM-Tg-cang-IP1781-Ab-2;
GM-Tg-bovg-IP1781-Ab-1/ GM-Tg-bovg-IP1781-Ab-2; GM-Tg-equg-IP1781-Ab-1/ GM-Tg-equg-IP1781-Ab-2
Products NameAnti-SNPH monoclonal antibody
Formatmab
Target NameSNPH
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SNPH monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1781-Ag-1Recombinant multi-species SNPH protein


    Target information

    Target IDGM-IP1781
    Target NameSNPH
    Gene ID9751,241727,296267,100429237,485812,109498513,512054,100067697
    Gene Symbol and Synonyms6430515A01,mKIAA0374,SNPH
    Uniprot AccessionO15079,B5DF41
    Uniprot Entry NameSNPH_HUMAN,SNPH_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000101298
    Target ClassificationN/A

    The target: SNPH, gene name: SNPH, also named as . Syntaxin-1, synaptobrevin/VAMP, and SNAP25 interact to form the SNARE complex, which is required for synaptic vesicle docking and fusion. The protein encoded by this gene is membrane-associated and inhibits SNARE complex formation by binding free syntaxin-1. Expression of this gene appears to be brain-specific. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.